Statement of Cash Flows	11 Months Ended	12 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($)
Cash flows from operating activities:
Net income	$ 4,347,000	$ 12,707,000
Adjustments to reconcile net income to net cash used in operating activities:
Payment by Founders of formation costs	5,000	0
Income from cash and investments held in Trust Account	(4,000)	(2,942,000)
Warrant liability issuance costs	491,000	0
Change in fair value of warrant liability	(5,125,000)	(10,455,000)
Changes in operating assets and liabilities:
Decrease (increase) in prepaid expenses	(409,000)	242,000
Increase in accounts payable (excluding offering costs of $107,000 in 2021)	40,000	33,000
Increase (decrease) in accrued liabilities	79,000	(60,000)
Net cash used in operating activities	(576,000)	(475,000)
Cash flows used in investing activities:
Cash deposited in Trust Account	(204,000,000)	(204,000,000)
Net cash used in operating activities	(204,000,000)
Cash flows from financing activities:
Proceeds from Sponsor Note	240,000	0
Proceeds from sale of Units to the public	200,000,000	0
Proceeds from sale of Private Placement Warrants	10,500,000	0
Payment of underwriting discounts	(4,000,000)	0
Payment of deferred offering costs	(598,000)	(107,000)
Payment of Note payable to Sponsor	(240,000)	0
Net cash (used in) provided by financing activities	205,902,000	(107,000)
Net change in cash	1,326,000	(582,000)
Cash at beginning of period	0	1,326,000
Cash at end of period	1,326,000	744,000
Supplemental disclosure of non-cash financing activities:
Deferred offering costs included in accounts payable	107,000	0
Deferred underwriters' compensation (reduction)	7,000,000	(3,325,000)
Remeasurement of carrying value to redemption value of Class A Ordinary shares subject to redemption	$ 0	$ 2,942,000